A citation-based method for searching scientific literature

Nicholas J Gadsden, Cory D Fulcher, Daniel Li, Nitisha Shrivastava, Carlos Thomas, Jeffrey E Segall, Michael B Prystowsky, Nicolas F Schlecht, Evripidis Gavathiotis, Thomas J Ow. Mol Cancer Res 2021
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
100

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Maura L Gillison, Andy M Trotti, Jonathan Harris, Avraham Eisbruch, Paul M Harari, David J Adelstein, Richard C K Jordan, Weiqiang Zhao, Erich M Sturgis, Barbara Burtness,[...]. Lancet 2019
379
100

Biomarker-Guided Development of DNA Repair Inhibitors.
James M Cleary, Andrew J Aguirre, Geoffrey I Shapiro, Alan D D'Andrea. Mol Cell 2020
25
50


ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.
Andrew N Blackford, Stephen P Jackson. Mol Cell 2017
575
50

The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.
T Fukusumi, J A Califano. J Dent Res 2018
29
50

Targeting DNA repair mechanisms in cancer.
John M Furgason, El Mustapha Bahassi. Pharmacol Ther 2013
84
50

ATR inhibition sensitizes HPV- and HPV+ head and neck squamous cell carcinoma to cisplatin.
Brandon C Leonard, Eliot D Lee, Neil E Bhola, Hua Li, Kristian K Sogaard, Christopher J Bakkenist, Jennifer R Grandis, Daniel E Johnson. Oral Oncol 2019
10
50


Functional genetic screens identify genes essential for tumor cell survival in head and neck and lung cancer.
Sanne R Martens-de Kemp, Remco Nagel, Marijke Stigter-van Walsum, Ida H van der Meulen, Victor W van Beusechem, Boudewijn J M Braakhuis, Ruud H Brakenhoff. Clin Cancer Res 2013
55
50

Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.
Shlomo A Koyfman, Nofisat Ismaila, Doug Crook, Anil D'Cruz, Cristina P Rodriguez, David J Sher, Damian Silbermins, Erich M Sturgis, Terance T Tsue, Jared Weiss,[...]. J Clin Oncol 2019
58
50

DNA Damage and Cancer Immunotherapy: A STING in the Tale.
Timo Reisländer, Florian J Groelly, Madalena Tarsounas. Mol Cell 2020
20
50

The cell cycle and cancer.
Gareth H Williams, Kai Stoeber. J Pathol 2012
293
50

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.
Hisham Mehanna, Max Robinson, Andrew Hartley, Anthony Kong, Bernadette Foran, Tessa Fulton-Lieuw, Matthew Dalby, Pankaj Mistry, Mehmet Sen, Lorcan O'Toole,[...]. Lancet 2019
310
50

Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
Stephanie E Smetsers, Eunike Velleuer, Ralf Dietrich, Thijs Wu, Arjen Brink, Marijke Buijze, Dorly J H Deeg, Jean Soulier, C René Leemans, Boudewijn J M Braakhuis,[...]. Cancer Prev Res (Phila) 2015
9
50

Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy.
Reinout H de Roest, Steven W Mes, Jos B Poell, Arjen Brink, Mark A van de Wiel, Elisabeth Bloemena, Elena Thai, Tito Poli, C René Leemans, Ruud H Brakenhoff. Clin Cancer Res 2019
7
50

Integrated analysis of DNA copy number and gene expression microarray data using gene sets.
Renée X Menezes, Marten Boetzer, Melle Sieswerda, Gert-Jan B van Ommen, Judith M Boer. BMC Bioinformatics 2009
42
50

Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck.
D Vicky de Boer, Sanne R Martens-de Kemp, Marijke Buijze, Marijke Stigter-van Walsum, Elisabeth Bloemena, Ralf Dietrich, C René Leemans, Victor W van Beusechem, Boudewijn J M Braakhuis, Ruud H Brakenhoff. Oncotarget 2017
9
50

Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol.
Anthony Kong, James Good, Amanda Kirkham, Joshua Savage, Rhys Mant, Laura Llewellyn, Joanna Parish, Rachel Spruce, Martin Forster, Stefano Schipani,[...]. BMJ Open 2020
7
50

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Fiona M Behan, Francesco Iorio, Gabriele Picco, Emanuel Gonçalves, Charlotte M Beaver, Giorgia Migliardi, Rita Santos, Yanhua Rao, Francesco Sassi, Marika Pinnelli,[...]. Nature 2019
280
50

Living with or without cyclins and cyclin-dependent kinases.
Charles J Sherr, James M Roberts. Genes Dev 2004
790
50

CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy.
Holly E Barker, Radhika Patel, Martin McLaughlin, Ulrike Schick, Shane Zaidi, Christopher M Nutting, Katie L Newbold, Shreerang Bhide, Kevin J Harrington. Mol Cancer Ther 2016
18
50

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas.
Mara Gilardi, Zhiyong Wang, Marco Proietto, Anastasia Chillà, Juan Luis Calleja-Valera, Yusuke Goto, Marco Vanoni, Matthew R Janes, Zbigniew Mikulski, Antonio Gualberto,[...]. Mol Cancer Ther 2020
9
50


Oral erythroplakia--a review.
Peter A Reichart, Hans Peter Philipsen. Oral Oncol 2005
134
50

Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment.
Qiu-Chi Ran, Sheng-Rong Long, Yan Ye, Chen Xie, Zhuo-Lin XuXiao, Yu-Song Liu, Hong-Xia Pang, Diwas Sunchuri, Nai-Chia Teng, Zhu-Ling Guo. J Dent Sci 2021
1
100

Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Loren Michel, Jessica Ley, Tanya M Wildes, András Schaffer, Anthony Robinson, Se-Eun Chun, Wooin Lee, James Lewis, Kathryn Trinkaus, Douglas Adkins. Oral Oncol 2016
50
50

Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities.
Jay Perry, Bruce Ashford, Amarinder Singh Thind, Marie-Emilie Gauthier, Elahe Minaei, Gretel Major, Narayanan Gopalakrishna Iyer, Ruta Gupta, Jonathan Clark, Marie Ranson. Int J Mol Sci 2020
2
50

Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells.
Wei Chen, Kun Yuan, Ze-Zhang Tao, Bo-Kui Xiao. Asian Pac J Cancer Prev 2011
12
50

Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
Stefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, Mara Serena Serafini, Silvana Canevari, Silvia Rossi, Davide Lanfranco, Frank J P Hoebers, Frederik W R Wesseling, Simon Keek,[...]. Head Neck 2021
4
50

Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
Petr Szturz, Kristien Wouters, Naomi Kiyota, Makoto Tahara, Kumar Prabhash, Vanita Noronha, Ana Castro, Lisa Licitra, David Adelstein, Jan B Vermorken. Oncologist 2017
49
50

Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure.
Raymond Pagliarini, Wenlin Shao, William R Sellers. EMBO Rep 2015
119
50

Fanconi anaemia and cancer: an intricate relationship.
Grzegorz Nalepa, D Wade Clapp. Nat Rev Cancer 2018
117
50

Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer.
Alexander Y Deneka, Margret B Einarson, John Bennett, Anna S Nikonova, Mohamed Elmekawy, Yan Zhou, Jong Woo Lee, Barbara A Burtness, Erica A Golemis. Cancers (Basel) 2020
4
50

Evaluation of Cyclin D1 expression in Head and Neck Squamous Cell Carcinoma.
Vishal Dhingra, Jyoti Verma, Vatsala Misra, Sapan Srivastav, Faheema Hasan. J Clin Diagn Res 2017
5
50

The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Joanne Smith, Lye Mun Tho, Naihan Xu, David A Gillespie. Adv Cancer Res 2010
698
50

Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Lawrence A Donehower, Thierry Soussi, Anil Korkut, Yuexin Liu, Andre Schultz, Maria Cardenas, Xubin Li, Ozgun Babur, Teng-Kuei Hsu, Olivier Lichtarge,[...]. Cell Rep 2019
87
50

Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma.
David S Hong, Kathleen Moore, Manish Patel, Stefan C Grant, Howard A Burris, William N William, Suzanne Jones, Funda Meric-Bernstam, Jeffrey Infante, Lisa Golden,[...]. Clin Cancer Res 2018
33
50

The changing landscape of phase I trials in oncology.
Kit Man Wong, Anna Capasso, S Gail Eckhardt. Nat Rev Clin Oncol 2016
40
50

Role of Immunotherapy in Head and Neck Cancer.
Diane C Ling, Chris J Bakkenist, Robert L Ferris, David A Clump. Semin Radiat Oncol 2018
36
50

Cell-Cycle Therapeutics Come of Age.
Matthew Ingham, Gary K Schwartz. J Clin Oncol 2017
130
50

Predicting survival in head and neck squamous cell carcinoma from TP53 mutation.
David L Masica, Shuli Li, Christopher Douville, Judith Manola, Robert L Ferris, Barbara Burtness, Arlene A Forastiere, Wayne M Koch, Christine H Chung, Rachel Karchin. Hum Genet 2015
17
50

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.
Stephen Mf Jamieson, Peter Tsai, Maria K Kondratyev, Pratha Budhani, Arthur Liu, Neil N Senzer, E Gabriela Chiorean, Shadia I Jalal, John J Nemunaitis, Dennis Kee,[...]. JCI Insight 2018
23
50


Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway.
David Lopez-Martinez, Chih-Chao Liang, Martin A Cohn. Cell Mol Life Sci 2016
58
50

Integrating Old and New Paradigms of G1/S Control.
Seth M Rubin, Julien Sage, Jan M Skotheim. Mol Cell 2020
16
50

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.
Guodong Fu, Raj Thani Somasundaram, Fatima Jessa, Gunjan Srivastava, Christina MacMillan, Ian Witterick, Paul G Walfish, Ranju Ralhan. Oncotarget 2016
5
50


Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status.
Hind Hafsi, Magnus T Dillon, Holly E Barker, Joan N Kyula, Ulrike Schick, James T Paget, Henry G Smith, Malin Pedersen, Martin McLaughlin, Kevin J Harrington. Front Oncol 2018
20
50

Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.
Erea Brouns, Ja Baart, Kh Karagozoglu, Iha Aartman, E Bloemena, I van der Waal. Oral Dis 2014
71
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.